| 标题 |
36P First-line limertinib versus gefitinib in EGFR-mutated advanced NSCLC: Updated overall survival results from a randomized, double-blind, phase III trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:Y-K. Shi; L. Wu; Y. Ji; G. Chen; B. Li; et al 出版日期:2026-03-17 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)